This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Broadspire® Hosts First Pharmacy Summit

ATLANTA, March 21, 2012 /PRNewswire/ -- Broadspire, a Crawford Company and leading third party administrator (TPA) and medical management services provider, will bring together representatives from a number of key industry organizations to discuss challenges in prescription drug management for workers compensation claims during its first pharmacy summit Thursday.

"The intention of the summit is to focus on global industry issues, trends and developments in the future," said Danielle Lisenbey, Broadspire's chief executive officer. "One of our key objectives is to help identify common threads that tie together claimant, payer, employer and carrier interests. We expect to share ideas that we can put into practice to improve outcomes for everyone concerned."

More than 50 brokers, practice leaders, clinicians and others from major insurers, insurance brokerage firms and pharmacy benefit management (PBM) organizations will attend the summit, which will be held at Broadspire's Sunrise, Fla., medical management headquarters. Broadspire medical management personnel and representatives of the attending organizations will be featured speakers.

The summit will include sessions on the following topics:
  • Pharmacy program measurement and outcomes
  • Mail order prescription services in workers compensation programs
  • Opioid prescription monitoring and management
  • Physician dispensing of prescription drugs for workers compensation claims
  • Jurisdictional updates on topics such as compound medications and for states including Florida, Texas, California and Illinois.

Workers compensation prescription drug use is on the rise and accounts for 19 percent of all medical costs related to work comp claims, according to the National Council on Compensation Insurance (NCCI), which manages the nation's largest database of workers compensation insurance information. In addition to issues with dispensing methods and overall costs, the increasing use of opioid pain medications, with their potential for abuse and addiction, is a particular concern.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,061.92 +11.17 0.07%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,815.5790 +4.7910 0.10%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs